Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14657
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study

Hepatology
MedicineHepatology
2018English

Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

Hepatitis Monthly
HepatologyInfectious Diseases
2013English

Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a

Virology Journal
VirologyInfectious Diseases
2019English

Interferon and Lamivudine vs. Interferon for Hepatitis B E Antigen-Positive Hepatitis B Treatment: Meta-Analysis of Randomized Controlled Trials

Liver International
Hepatology
2007English

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients With Elevated Hepatitis B Virus DNA Levels

PLoS ONE
Multidisciplinary
2015English

Randomised Controlled Trial of Interferon Alfa (Lymphoblastoid Interferon) in Chronic Non-A Non-B Hepatitis.

BMJ
1989English

Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.

Gut
Gastroenterology
1993English

A Case of Hepatitis B Surface Antigen Positive Chronic Hepatitis With Sarcoidosis.

Acta Hepatologica Japonica
Hepatology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy